Analyst Profile

Followed by 116 followers
.
Tim Chiang

Tim Chiang

Capital One Financial
Wall Street Analyst
#7,965 out of 8,160 Wall Street Analysts
#23,774 out of 24,427 experts

Success Rate

39%
84 out of 216 transactions made a profit

Average Return

-12.70%
Average return per transaction
Time Frame
1 Year
Compare to
No Benchmark
Copying Tim Chiang's trades since 2013 and holding each position for 1 Year would result in 38.89% of your transactions generating a profit, with an average return of -12.7% per rating.

Stock Rating Distribution

341Ratings
80.06% Buy
18.77% Hold
1.17% Sell
Distribution of Tim Chiang's ratings

Additional Information

Main Sector:Healthcare
Geo Coverage:
United StatesUS Market

Best Rating

Stock:
Relypsa Inc
(RLYP)
Rating:Buy
Date:Mar 16, 2016 - Sep 01, 2016
Return:+164.90%
The most profitable rating made by Tim Chiang

Tim Chiang's Stock Coverage

Company
Date
Position
Action
Price Target
No. of Ratings
Success Rate
Avg. Return
Endo International
May 13, 2013
Hold
Downgraded
1Ratings
0.00%
HITK
Hi-Tech Pharmacal Co., Inc.
Aug 27, 2013
Hold
Downgraded
1Ratings
0.00%
~FRX
Forest Labs
Feb 19, 2014
Hold
Downgraded
2Ratings
100%
+35.80%
QCOR
Questcor
Feb 26, 2014
Hold
Reiterated
3Ratings
100%
+43.80%
MNKKQ
Mallinckrodt
Jan 30, 2015
Hold
Reiterated
$97.00
(484900.00% Upside)
3Ratings
0%
-55.70%
AGN
Allergan
Feb 19, 2015
Buy
Reiterated
6Ratings
83%
+30.17%
RLYP
Relypsa Inc
Sep 01, 2016
Hold
Downgraded
14Ratings
100%
+83.43%
~TIG
Tigenix NV
Jan 16, 2018
Hold
Downgraded
1Ratings
0.00%
SHPG
Shire
Apr 26, 2018
Buy
Reiterated
18Ratings
71%
+24.36%
Bausch Health Companies
Jun 19, 2018
Hold
Reiterated
23Ratings
40%
-21.66%
List of latest recommendations made by Tim Chiang. Click to expand and see Tim Chiang's performance on a particular stock
Disclaimer: TipRanks collects analysts’ ratings and price targets by scanning publicly available reports on financial websites and by receiving reports from analysts, firms, or customers. The information and statistics displayed might not be accurate, complete, or up-to-date. The analyst ratings provided are the sole responsibility of the source publication. TipRanks holds no liability over the analysts' information, price targets, ratings, or opinions expressed.
Send Us Reports
If you receive reports that you think we are missing, we will thank you with a free Ultimate upgrade!
Learn More >